Microbiome and complications of liver disease.
作者信息
Bajaj Jasmohan S
机构信息
Division of Gastroenterology, Hepatology and Nutrition Virginia Commonwealth University and McGuire VA Medical Center Richmond VA.
出版信息
Clin Liver Dis (Hoboken). 2015 May 7;5(4):96-99. doi: 10.1002/cld.460. eCollection 2015 Apr.
Abstract
摘要
相似文献
1
Microbiome and complications of liver disease.
Clin Liver Dis (Hoboken). 2015 May 7;5(4):96-99. doi: 10.1002/cld.460. eCollection 2015 Apr.
2
Role of the intestinal microbiome in liver fibrosis development and new treatment strategies.
Transl Res. 2019 Jul;209:22-38. doi: 10.1016/j.trsl.2019.02.005. Epub 2019 Feb 16.
3
Gut Microbiota and Complications of Liver Disease.
Gastroenterol Clin North Am. 2017 Mar;46(1):155-169. doi: 10.1016/j.gtc.2016.09.013.
4
Clinical impact of microbiome in patients with decompensated cirrhosis.
World J Gastroenterol. 2018 Sep 14;24(34):3813-3820. doi: 10.3748/wjg.v24.i34.3813.
5
The Metabolic Role of the Microbiome: Implications for NAFLD and the Metabolic Syndrome.
Semin Liver Dis. 2016 Sep;36(4):312-316. doi: 10.1055/s-0036-1593880. Epub 2016 Dec 20.
6
The intestinal microbiome and paediatric liver disease.
Lancet Gastroenterol Hepatol. 2017 Jun;2(6):446-455. doi: 10.1016/S2468-1253(16)30241-2.
7
Microbial Profiles of Cirrhosis in the Human Small Intestine.
Curr Gastroenterol Rep. 2019 Aug 23;21(10):50. doi: 10.1007/s11894-019-0717-2.
8
Omics for Understanding the Gut-Liver-Microbiome Axis and Precision Medicine.
Clin Pharmacol Drug Dev. 2017 Mar;6(2):176-185. doi: 10.1002/cpdd.310.
9
The Gut Microbiota and Nonalcoholic Fatty Liver Disease.
Semin Liver Dis. 2015 Aug;35(3):262-9. doi: 10.1055/s-0035-1562946. Epub 2015 Sep 17.
10
[The role of gut microbiota in chronic liver diseases, and treatment possibilities].
Orv Hetil. 2018 Sep;159(36):1465-1474. doi: 10.1556/650.2018.31178.
本文引用的文献
1
Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy.
Hepatology. 2015 Oct;62(4):1260-71. doi: 10.1002/hep.27819. Epub 2015 May 6.
2
Commensal microbiota is hepatoprotective and prevents liver fibrosis in mice.
FASEB J. 2015 Mar;29(3):1043-55. doi: 10.1096/fj.14-259515. Epub 2014 Dec 2.
3
Microbial therapy in liver disease: probiotics probe the microbiome-gut-liver-brain axis.
Gastroenterology. 2014 Dec;147(6):1216-8. doi: 10.1053/j.gastro.2014.10.023.
4
Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.
Am J Physiol Gastrointest Liver Physiol. 2014 Nov 15;307(10):G951-7. doi: 10.1152/ajpgi.00268.2014. Epub 2014 Sep 25.
5
Long-term use of antibiotics and proton pump inhibitors predict development of infections in patients with cirrhosis.
Clin Gastroenterol Hepatol. 2015 Apr;13(4):753-9.e1-2. doi: 10.1016/j.cgh.2014.07.060. Epub 2014 Aug 12.
6
Alterations of the human gut microbiome in liver cirrhosis.
Nature. 2014 Sep 4;513(7516):59-64. doi: 10.1038/nature13568. Epub 2014 Jul 23.
7
The role of microbiota in hepatic encephalopathy.
Gut Microbes. 2014 May-Jun;5(3):397-403. doi: 10.4161/gmic.28684. Epub 2014 Apr 1.
8
Effect of various antibiotics on modulation of intestinal microbiota and bile acid profile in mice.
Toxicol Appl Pharmacol. 2014 Jun 1;277(2):138-45. doi: 10.1016/j.taap.2014.03.009. Epub 2014 Mar 20.
9
Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis.
Aliment Pharmacol Ther. 2014 May;39(10):1113-25. doi: 10.1111/apt.12695. Epub 2014 Mar 16.
10
Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics.
BMC Gastroenterol. 2014 Feb 24;14:40. doi: 10.1186/1471-230X-14-40.
Zotero 插件